National venture investments declined during the third quarter of 2006, but remained above the $6 billion level for the third consecutive quarter, according to a MoneyTree Report by PricewaterhouseCoopers and the National Venture Capital Association based on data from Thomson Financial. For the first time,...
TomoTherapy Inc. has reached a milestone by selling its 100th Hi-Art System to a veterans medical center in Albany, N.Y. The Stratton VA Medical Center will use the system, which applies a targeted dosage of radiation, to treat veterans with prostate cancer, head and neck...
Mirus Bio Corp. has been granted a European patent for its therapeutic gene delivery technique known as "Pathway IV," which could one day help treat muscular dystrophy and Lou Gehrig's disease. The Madison-based biotech company is actively seeking strategic alliances to expand its product pipeline. ...
Wisconsin has many economic assets, but it still may not be able to compete with the more nimble and more moneyed east and west coasts. In this latest installment of WTN's Visions Series, Baird CEO Paul Purcell recommends nixing intra- and inter-state rivalries as he...
A Wauwatosa-based biotechnology firm developing an instrument for testing new drugs on genetically-engineered heart tissue has been awarded almost $100,000 from the National Institutes of Health. InvivoSciences will use the money to optimize its technology for commercialization in 2007....
A research team led by pediatric hematologist Robert Montgomery has received a five-year, $9.7 million project grant to conduct genetic studies into a hereditary bleeding disorder known as Von Willebrand disease. The grant was issued by the National Heart, Lung, and Blood Institute....
Imago Scientific Instruments has sold one of its atom probe microscopes to Iowa State University's College of Engineering for use later this fall. According to the company, the microscope could lead to advances in energy, healthcare, and anti-terrorism efforts....
Madison's bioscience business community is widely known as one of the premier locations for research collaboration and growth, but the arrival of Northwestern University's Caden Biosciences could be a sign that Madison has reached a "critical mass" of talent and technological resources....
A recent visit to the Land of the Rising Sun has Yer Biotech Blues columnist Michael Rosen thinking international. Given the resurgence of the Japanese biotechnology industry, he believes the time is right for companies in the Midwest to build stronger ties to both the...
In a surprise announcement, Elizabeth Donley, who has served as executive director of the WiCell Research Institute since early September, has announced her resignation. Since 1998, Donley served in a variety of capacities for WiCell and the Wisconsin Alumni Research Foundation, but left to pursue...